These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 19580665)

  • 1. Stopping randomized trials early for benefit: a protocol of the Study Of Trial Policy Of Interim Truncation-2 (STOPIT-2).
    Briel M; Lane M; Montori VM; Bassler D; Glasziou P; Malaga G; Akl EA; Ferreira-Gonzalez I; Alonso-Coello P; Urrutia G; Kunz R; Culebro CR; da Silva SA; Flynn DN; Elamin MB; Strahm B; Murad MH; Djulbegovic B; Adhikari NK; Mills EJ; Gwadry-Sridhar F; Kirpalani H; Soares HP; Abu Elnour NO; You JJ; Karanicolas PJ; Bucher HC; Lampropulos JF; Nordmann AJ; Burns KE; Mulla SM; Raatz H; Sood A; Kaur J; Bankhead CR; Mullan RJ; Nerenberg KA; Vandvik PO; Coto-Yglesias F; Schünemann H; Tuche F; Chrispim PP; Cook DJ; Lutz K; Ribic CM; Vale N; Erwin PJ; Perera R; Zhou Q; Heels-Ansdell D; Ramsay T; Walter SD; Guyatt GH
    Trials; 2009 Jul; 10():49. PubMed ID: 19580665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic reviewers neglect bias that results from trials stopped early for benefit.
    Bassler D; Ferreira-Gonzalez I; Briel M; Cook DJ; Devereaux PJ; Heels-Ansdell D; Kirpalani H; Meade MO; Montori VM; Rozenberg A; Schünemann HJ; Guyatt GH
    J Clin Epidemiol; 2007 Sep; 60(9):869-73. PubMed ID: 17689802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized trials stopped early for benefit: a systematic review.
    Montori VM; Devereaux PJ; Adhikari NK; Burns KE; Eggert CH; Briel M; Lacchetti C; Leung TW; Darling E; Bryant DM; Bucher HC; Schünemann HJ; Meade MO; Cook DJ; Erwin PJ; Sood A; Sood R; Lo B; Thompson CA; Zhou Q; Mills E; Guyatt GH
    JAMA; 2005 Nov; 294(17):2203-9. PubMed ID: 16264162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reflections on meta-analyses involving trials stopped early for benefit: is there a problem and if so, what is it?
    Bassler D; Montori VM; Briel M; Glasziou P; Walter SD; Ramsay T; Guyatt G
    Stat Methods Med Res; 2013 Apr; 22(2):159-68. PubMed ID: 22170891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stopping randomized trials early for benefit and estimation of treatment effects: systematic review and meta-regression analysis.
    Bassler D; Briel M; Montori VM; Lane M; Glasziou P; Zhou Q; Heels-Ansdell D; Walter SD; Guyatt GH; ; Flynn DN; Elamin MB; Murad MH; Abu Elnour NO; Lampropulos JF; Sood A; Mullan RJ; Erwin PJ; Bankhead CR; Perera R; Ruiz Culebro C; You JJ; Mulla SM; Kaur J; Nerenberg KA; Schünemann H; Cook DJ; Lutz K; Ribic CM; Vale N; Malaga G; Akl EA; Ferreira-Gonzalez I; Alonso-Coello P; Urrutia G; Kunz R; Bucher HC; Nordmann AJ; Raatz H; da Silva SA; Tuche F; Strahm B; Djulbegovic B; Adhikari NK; Mills EJ; Gwadry-Sridhar F; Kirpalani H; Soares HP; Karanicolas PJ; Burns KE; Vandvik PO; Coto-Yglesias F; Chrispim PP; Ramsay T
    JAMA; 2010 Mar; 303(12):1180-7. PubMed ID: 20332404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initiation and continuation of randomized trials after the publication of a trial stopped early for benefit asking the same study question: STOPIT-3 study design.
    Prutsky GJ; Domecq JP; Erwin PJ; Briel M; Montori VM; Akl EA; Meerpohl JJ; Bassler D; Schandelmaier S; Walter SD; Zhou Q; Coello PA; Moja L; Walter M; Thorlund K; Glasziou P; Kunz R; Ferreira-Gonzalez I; Busse J; Sun X; Kristiansen A; Kasenda B; Qasim-Agha O; Pagano G; Pardo-Hernandez H; Urrutia G; Murad MH; Guyatt G
    Trials; 2013 Oct; 14():335. PubMed ID: 24131702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantifying over-estimation in early stopped clinical trials and the "freezing effect" on subsequent research.
    Wang H; Rosner GL; Goodman SN
    Clin Trials; 2016 Dec; 13(6):621-631. PubMed ID: 27271682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early stopping of randomized clinical trials for overt efficacy is problematic.
    Bassler D; Montori VM; Briel M; Glasziou P; Guyatt G
    J Clin Epidemiol; 2008 Mar; 61(3):241-6. PubMed ID: 18226746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A systematic survey of randomised trials that stopped early for reasons of futility.
    Walter SD; Han H; Guyatt GH; Bassler D; Bhatnagar N; Gloy V; Schandelmaier S; Briel M
    BMC Med Res Methodol; 2020 Jan; 20(1):10. PubMed ID: 31948397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An analysis of protocols and publications suggested that most discontinuations of clinical trials were not based on preplanned interim analyses or stopping rules.
    Stegert M; Kasenda B; von Elm E; You JJ; Blümle A; Tomonaga Y; Saccilotto R; Amstutz A; Bengough T; Briel M;
    J Clin Epidemiol; 2016 Jan; 69():152-60. PubMed ID: 26361993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A systematic review of the reporting of Data Monitoring Committees' roles, interim analysis and early termination in pediatric clinical trials.
    Fernandes RM; van der Lee JH; Offringa M
    BMC Pediatr; 2009 Dec; 9():77. PubMed ID: 20003383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized trials stopped early for harm in HIV/AIDS: a systematic survey.
    Mills E; Cooper C; Wu P; Rachlis B; Singh S; Guyatt GH
    HIV Clin Trials; 2006; 7(1):24-33. PubMed ID: 16684642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reporting on data monitoring committees in neonatal randomised controlled trials is inconsistent.
    Perrem LM; Gosling S; Ravikumar I; Khashan AS; Miletin J; Ryan CA; Dempsey E
    Acta Paediatr; 2017 Jan; 106(1):30-33. PubMed ID: 27637413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence-based medicine, systematic reviews, and guidelines in interventional pain management: part 6. Systematic reviews and meta-analyses of observational studies.
    Manchikanti L; Datta S; Smith HS; Hirsch JA
    Pain Physician; 2009; 12(5):819-50. PubMed ID: 19787009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How should we evaluate the risk of bias of physical therapy trials?: a psychometric and meta-epidemiological approach towards developing guidelines for the design, conduct, and reporting of RCTs in Physical Therapy (PT) area: a study protocol.
    Armijo-Olivo S; Fuentes J; Rogers T; Hartling L; Saltaji H; Cummings GG
    Syst Rev; 2013 Sep; 2():88. PubMed ID: 24070072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overestimation of benefit when clinical trials stop early: a simulation study.
    Liu S; Garrison SR
    Trials; 2022 Sep; 23(1):747. PubMed ID: 36064448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantifying the bias in the estimated treatment effect in randomized trials having interim analyses and a rule for early stopping for futility.
    Walter SD; Han H; Briel M; Guyatt GH
    Stat Med; 2017 Apr; 36(9):1506-1518. PubMed ID: 28183155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Issues in data monitoring and interim analysis of trials.
    Grant AM; Altman DG; Babiker AB; Campbell MK; Clemens FJ; Darbyshire JH; Elbourne DR; McLeer SK; Parmar MK; Pocock SJ; Spiegelhalter DJ; Sydes MR; Walker AE; Wallace SA;
    Health Technol Assess; 2005 Mar; 9(7):1-238, iii-iv. PubMed ID: 15763038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early stopping rules in oncology: considerations for clinicians.
    Mukherjee SD; Goffin JR; Taylor V; Anderson KK; Pond GR
    Eur J Cancer; 2011 Nov; 47(16):2381-6. PubMed ID: 21684153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.